Accepting new patients (614) 430-8022 7965 N High St, Suite 205
Optimed Immunology
Patient Portal Schedule Consultation

What is Asceniv?

Asceniv is a 10% IVIG product from ADMA Biologics, manufactured with elevated antibody titers against respiratory syncytial virus (RSV) and other respiratory pathogens. It is FDA-approved for primary humoral immunodeficiency in adults and adolescents.

What it treats

Asceniv is FDA-approved for the following indications:

  • Primary humoral immunodeficiency in adults and adolescents

How it is administered

Asceniv is administered intravenously every three to four weeks, with infusion options at home, in our suite, or at a partner center.

Patient assistance & support

The manufacturer offers a patient support program — ADMA Patient Support — that can help with insurance navigation, copay assistance for eligible patients, nursing support, and ongoing education. More information is available at https://www.admabiologics.com.

Coordination at Optimed Immunology

Treatment with Asceniv is initiated and monitored by Dr. McNeil. Prior authorizations are handled in-house — patients are not asked to navigate insurance approvals on their own. Infusion logistics are coordinated through trusted partner infusion providers — including Horizon Infusions, where the practice is co-located — or arranged for home infusion when appropriate. The team handles scheduling, nursing coordination, and prior-authorization renewals.

A note on age: The FDA indications above may include pediatric or adolescent age groups. Optimed Immunology's clinical practice is focused on adults. If you are seeking care for a minor, please contact the office and we can advise on referral options.

Important safety note: This page is not a substitute for the FDA prescribing information. Risks, contraindications, drug interactions, and required monitoring vary by patient. The official manufacturer website (https://www.asceniv.com) provides the most current full prescribing and safety information. Treatment decisions and monitoring are individualized — please discuss with Dr. McNeil whether Asceniv is appropriate for your situation.

Medically reviewed

Donald L. McNeil, MD · Board Certified in Allergy & Immunology and Internal Medicine

Last reviewed: November 2025 · Sources: FDA prescribing information · manufacturer label · AAAAI · ACAAI · relevant clinical guidelines

This page is provided for educational purposes only and is not medical advice. If you have an emergency, call 911.

Have questions about Asceniv?

Treatment selection is a shared decision. Schedule a consultation with Dr. McNeil to discuss whether Asceniv is appropriate for you.